Linda Goodman

Bio:

Linda Goodman is a co-founder and the CTO at Fauna Bio, a San Francisco Bay Area pre-clinical biotech company that utilizes natural animal models of disease resistance and AI approaches to design therapies for human diseases of high unmet need. Linda’s expertise spans human medical genetics and comparative mammalian genomics. She was a postdoctoral scholar at Stanford University and the Broad Institute, and she holds a PhD from Harvard University and an MPhil in Computational Biology from Cambridge University.